Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
22/09/2026 15:31
BRIEF-Alligator Bioscience Announces Final Outcome In Rights Issue Sept 22 (Reuters) - Alligator Bioscience AB ATORX.ST:
ALLIGATOR BIOSCIENCE: ALLIGATOR BIOSCIENCE ANNOUNCES FINAL OUTCOME IN RIGHTS ISSUE
523,797,503 UNITS, OR 16.7% OF RIGHTS ISSUE, SUBSCRIBED BY UNIT RIGHTS
RIGHTS ISSUE SUBSCRIBED TO 17.1%; GUARANTEE COMMITMENTS UTILIZED FOR 29.7%
RECEIVES SEK 58.8 MILLION BEFORE ISSUE COSTS AND BRIDGE LOAN REPAYMENT
Source text: ID:nMFN2lZsp3
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue